The US Atherosclerosis Therapeutics Market is growing due to the increasing demand for therapies that manage atherosclerotic cardiovascular disease and associated risk factors. Rising prevalence of dyslipidemia, diabetes, hypertension, and other cardiovascular risk factors is supporting treatment demand. Continued pharmaceutical innovation and increasing adoption of advanced lipid-lowering and...